Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Royalty Pharma plc (RPRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-K10-KS-1
Revenues  2,289.52,122.41,814.31,794.91,597.9
            Revenue growth  7.9%17.0%1.1%12.3% 
Cost of goods sold  452.8230.8-1,019.3430.4453.4
Gross profit  1,836.61,891.52,833.61,364.41,144.5
            Gross margin  80.2%89.1%156.2%76.0%71.6%
Selling, general and administrative   [+]182.8181.7103.461.9106.4
Research and development  200.126.383.0392.6117.9
Equity in earnings  -19.544.5-32.5-7.0163.8
Other operating expenses   65.1 -487.8 
EBITDA   [+]1,457.21,686.02,638.51,424.01,117.3
            EBITDA margin  63.6%79.4%145.4%79.3%69.9%
Depreciation  23.023.123.933.333.3
EBITA  1,434.21,662.92,614.61,390.71,084.0
            EBITA margin  62.6%78.4%144.1%77.5%67.8%
Amortization of intangibles  23.023.123.933.333.3
EBIT   [+]1,411.21,639.92,590.71,357.41,050.7
            EBIT margin  61.6%77.3%142.8%75.6%65.8%
Non-recurring items   [+]    -52.8
Interest expense, net   [+]112.6128.7246.2255.5240.6
Other income (expense), net   [+]-57.4190.8117.0415.9480.3
Pre-tax income  1,241.21,702.02,461.41,517.91,343.2
Income taxes  0.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%
Minority interest  621.5726.9112.9140.1133.2
Net income  619.7975.02,348.51,377.71,210.0
            Net margin  27.1%45.9%129.4%76.8%75.7%
   
Basic EPS   [+]$1.49$2.60   
Diluted EPS   [+]$1.49$2.60   
   
Dividends per share   [+]$0.68$0.30   
   
Shares outstanding (basic)   [+]414.8375.4   
Shares outstanding (diluted)   [+]414.8375.5   
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy